Skip to main content
Top
Published in: AIDS and Behavior 12/2015

01-12-2015 | Original Paper

HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling

Authors: Alexander R. Bazazi, Forrest Crawford, Alexei Zelenev, Robert Heimer, Adeeba Kamarulzaman, Frederick L. Altice

Published in: AIDS and Behavior | Issue 12/2015

Login to get access

Abstract

The HIV epidemic in Malaysia is concentrated among people who inject drugs (PWID). Accurate estimates of HIV prevalence are critical for developing appropriate treatment and prevention interventions for PWID in Malaysia. In 2010, 461 PWID were recruited using respondent-driven sampling in Greater Kuala Lumpur, Malaysia. Participants completed rapid HIV testing and behavioral assessments. Estimates of HIV prevalence were computed for each of the three recruitment sites and the overall sample. HIV prevalence was 15.8 % (95 % CI 12.5–19.2 %) overall but varied widely by location: 37.0 % (28.6–45.4 %) in Kampung Baru, 10.3 % (5.0–15.6 %) in Kajang, and 6.3 % (3.0–9.5 %) in Shah Alam. Recruitment extended to locations far from initial interview sites but was concentrated around discrete geographic regions. We document the high prevalence of HIV among PWID in Greater Kuala Lumpur. Sustained support for community surveillance and HIV prevention interventions is needed to stem the HIV epidemic among PWID in Malaysia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Malaysia Country Responses to HIV/AIDS. Reporting period: January 2013–December 2013: AIDS/STD Section, Diseases Control Division, Ministry of Health, Government of Malaysia. 2014. Malaysia Country Responses to HIV/AIDS. Reporting period: January 2013–December 2013: AIDS/STD Section, Diseases Control Division, Ministry of Health, Government of Malaysia. 2014.
2.
go back to reference Kamarulzaman A. Impact of HIV prevention programs on drug users in Malaysia. JAIDS J Acquir Immune Defic Syndr. 2009;52:S17–9.CrossRefPubMed Kamarulzaman A. Impact of HIV prevention programs on drug users in Malaysia. JAIDS J Acquir Immune Defic Syndr. 2009;52:S17–9.CrossRefPubMed
3.
go back to reference Malaysian AIDS Council, Malaysian AIDS Foundation. 2013 Annual Report. 2014. Malaysian AIDS Council, Malaysian AIDS Foundation. 2013 Annual Report. 2014.
4.
go back to reference Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A. Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers. PLoS One. 2012;7(9):e44249.PubMedCentralCrossRefPubMed Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A. Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers. PLoS One. 2012;7(9):e44249.PubMedCentralCrossRefPubMed
5.
go back to reference Degenhardt L, Mathers BM, Wirtz AL, et al. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010–2012? A review of the six highest burden countries. Int J Drug Policy. 2014;25(1):53–60.CrossRefPubMed Degenhardt L, Mathers BM, Wirtz AL, et al. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010–2012? A review of the six highest burden countries. Int J Drug Policy. 2014;25(1):53–60.CrossRefPubMed
6.
go back to reference Ghani MA, Brown SE, Khan F, et al. An exploratory qualitative assessment of self-reported treatment outcomes and satisfaction among patients accessing an innovative voluntary drug treatment centre in Malaysia. Int J Drug Policy. 2015;26(2):175–82.CrossRefPubMed Ghani MA, Brown SE, Khan F, et al. An exploratory qualitative assessment of self-reported treatment outcomes and satisfaction among patients accessing an innovative voluntary drug treatment centre in Malaysia. Int J Drug Policy. 2015;26(2):175–82.CrossRefPubMed
7.
go back to reference Jin H, Earnshaw VA, Wickersham JA, et al. An assessment of health-care students’ attitudes toward patients with or at high risk for HIV: implications for education and cultural competency. AIDS Care. 2014;26(10):1223–8.PubMedCentralCrossRefPubMed Jin H, Earnshaw VA, Wickersham JA, et al. An assessment of health-care students’ attitudes toward patients with or at high risk for HIV: implications for education and cultural competency. AIDS Care. 2014;26(10):1223–8.PubMedCentralCrossRefPubMed
8.
go back to reference Act 234: Dangerous drugs act 1952, revised. 2006. Act 234: Dangerous drugs act 1952, revised. 2006.
9.
go back to reference Act 283: Drug dependents (Treatment and rehabilitations) act 1983, revised. 2006. Act 283: Drug dependents (Treatment and rehabilitations) act 1983, revised. 2006.
10.
go back to reference Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44:174–99.CrossRef Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44:174–99.CrossRef
11.
go back to reference Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol. 2004;34(1):193–240.CrossRef Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol. 2004;34(1):193–240.CrossRef
13.
go back to reference Malekinejad M, Johnston LG, Kendall C, Kerr LRFS, Rifkin MR, Rutherford GW. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008;12(1):105–30.CrossRef Malekinejad M, Johnston LG, Kendall C, Kerr LRFS, Rifkin MR, Rutherford GW. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008;12(1):105–30.CrossRef
14.
go back to reference Centers for Disease Control and Prevention. HIV infection and HIV-associated behaviors among injecting drug users-20 cities, United States, 2009. MMWR. 2012;61(8):133. Centers for Disease Control and Prevention. HIV infection and HIV-associated behaviors among injecting drug users-20 cities, United States, 2009. MMWR. 2012;61(8):133.
15.
go back to reference World Health Organization. Introduction to HIV, AIDS and sexually transmitted infection surveillance. UNAIDS: World Health Organization; 2010. World Health Organization. Introduction to HIV, AIDS and sexually transmitted infection surveillance. UNAIDS: World Health Organization; 2010.
16.
go back to reference Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49(1):11–34.CrossRef Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49(1):11–34.CrossRef
17.
go back to reference Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. J Off Stat. 2008;24(1):79–97. Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. J Off Stat. 2008;24(1):79–97.
18.
go back to reference Gile KJ, Handcock MS. Network model-assisted inference from respondent-driven sampling data. arXiv preprint arXiv:1108.0298. 2011. Gile KJ, Handcock MS. Network model-assisted inference from respondent-driven sampling data. arXiv preprint arXiv:1108.0298. 2011.
19.
go back to reference Heimer R. Critical issues and further questions about respondent-driven sampling: comment on Ramirez-Valles, et al. (2005). AIDS Behav. 2005;9(4):403–8.CrossRefPubMed Heimer R. Critical issues and further questions about respondent-driven sampling: comment on Ramirez-Valles, et al. (2005). AIDS Behav. 2005;9(4):403–8.CrossRefPubMed
20.
22.
go back to reference Salganik MJ. Commentary: respondent-driven sampling in the real world. Epidemiology. 2012;23(1):148–50.CrossRefPubMed Salganik MJ. Commentary: respondent-driven sampling in the real world. Epidemiology. 2012;23(1):148–50.CrossRefPubMed
24.
go back to reference Crawford FW. The graphical structure of respondent-driven sampling. arXiv:1406.0721. 2014. Crawford FW. The graphical structure of respondent-driven sampling. arXiv:1406.0721. 2014.
25.
go back to reference Gile KJ, Johnston LG, Salganik MJ. Diagnostics for respondent-driven sampling. J R Stat Soc. 2015;178(1):241–69.CrossRef Gile KJ, Johnston LG, Salganik MJ. Diagnostics for respondent-driven sampling. J R Stat Soc. 2015;178(1):241–69.CrossRef
26.
go back to reference Salganik MJ. Variance estimation, design effects, and sample size calculations for respondent-driven sampling. J Urban Health. 2006;83(1):98–112.PubMedCentralCrossRef Salganik MJ. Variance estimation, design effects, and sample size calculations for respondent-driven sampling. J Urban Health. 2006;83(1):98–112.PubMedCentralCrossRef
27.
go back to reference McCarty C, Killworth PD, Bernard RH, Johnsen EC, Shelley GA. Comparing two methods for estimating network size. Hum Organ. 2001;60(1):28–39.CrossRef McCarty C, Killworth PD, Bernard RH, Johnsen EC, Shelley GA. Comparing two methods for estimating network size. Hum Organ. 2001;60(1):28–39.CrossRef
28.
go back to reference Sheehan DV, Lecrubier Y, Sheehan KH, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(20):22–33;quiz 34–57.PubMed Sheehan DV, Lecrubier Y, Sheehan KH, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(20):22–33;quiz 34–57.PubMed
31.
go back to reference Gile KJ. Improved inference for respondent-driven sampling data with application to HIV prevalence estimation. J Am Stat Assoc. 2011;106(493):135–46.CrossRef Gile KJ. Improved inference for respondent-driven sampling data with application to HIV prevalence estimation. J Am Stat Assoc. 2011;106(493):135–46.CrossRef
33.
go back to reference Wejnert C. An empirical test of respondent-driven sampling: point estimates, variance, degree measures, and out-of-equilibrium data. Sociol Methodol. 2009;39(1):73–116.PubMedCentralCrossRefPubMed Wejnert C. An empirical test of respondent-driven sampling: point estimates, variance, degree measures, and out-of-equilibrium data. Sociol Methodol. 2009;39(1):73–116.PubMedCentralCrossRefPubMed
34.
go back to reference Gabor C, Nepusz T. The igraph software package for complex network research. Int J Complex Syst. 2006. Gabor C, Nepusz T. The igraph software package for complex network research. Int J Complex Syst. 2006.
35.
go back to reference Bazazi AR, Zelenev A, Fu JJ, Yee I, Kamarulzaman A, Altice FL. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: correlates of overdose and implications for overdose prevention from a cross-sectional study. Int J Drug Policy. 2014. Bazazi AR, Zelenev A, Fu JJ, Yee I, Kamarulzaman A, Altice FL. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: correlates of overdose and implications for overdose prevention from a cross-sectional study. Int J Drug Policy. 2014.
36.
go back to reference Vijay A, Bazazi AR, Yee I, Kamarulzaman A, Altice FL. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia. J Subst Abus Treat. 2015;54:29–36.CrossRef Vijay A, Bazazi AR, Yee I, Kamarulzaman A, Altice FL. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia. J Subst Abus Treat. 2015;54:29–36.CrossRef
37.
go back to reference Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.CrossRefPubMed Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.CrossRefPubMed
38.
go back to reference Singh S, Crofts N. HIV infection among injecting drug users in north-east Malaysia, 1992. AIDS Care. 1993;5(3):273–81.CrossRefPubMed Singh S, Crofts N. HIV infection among injecting drug users in north-east Malaysia, 1992. AIDS Care. 1993;5(3):273–81.CrossRefPubMed
39.
go back to reference Vicknasingam B, Narayanan S, Navaratnam V. The relative risk of HIV among IDUs not in treatment in Malaysia. AIDS Care. 2009;21(8):984–91.CrossRefPubMed Vicknasingam B, Narayanan S, Navaratnam V. The relative risk of HIV among IDUs not in treatment in Malaysia. AIDS Care. 2009;21(8):984–91.CrossRefPubMed
40.
go back to reference De P, Cox J, Boivin JF, Platt RW, Jolly AM. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction. 2007;102(11):1730–9.CrossRefPubMed De P, Cox J, Boivin JF, Platt RW, Jolly AM. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction. 2007;102(11):1730–9.CrossRefPubMed
41.
go back to reference Costenbader EC, Astone NM, Latkin CA. The dynamics of injection drug users’ personal networks and HIV risk behaviors. Addiction. 2006;101(7):1003–13.CrossRefPubMed Costenbader EC, Astone NM, Latkin CA. The dynamics of injection drug users’ personal networks and HIV risk behaviors. Addiction. 2006;101(7):1003–13.CrossRefPubMed
42.
go back to reference Hoffmann JP, Su SS, Pach A. Changes in network characteristics and HIV risk behavior among injection drug users. Drug Alcohol Depend. 1997;46(1–2):41–51.CrossRefPubMed Hoffmann JP, Su SS, Pach A. Changes in network characteristics and HIV risk behavior among injection drug users. Drug Alcohol Depend. 1997;46(1–2):41–51.CrossRefPubMed
43.
go back to reference Rudolph AE, Fuller CM, Latkin C. The importance of measuring and accounting for potential biases in respondent-driven samples. AIDS Behav. 2013;17(6):2244–52.PubMedCentralCrossRefPubMed Rudolph AE, Fuller CM, Latkin C. The importance of measuring and accounting for potential biases in respondent-driven samples. AIDS Behav. 2013;17(6):2244–52.PubMedCentralCrossRefPubMed
44.
go back to reference Vickerman P, Platt L, Jolley E, Rhodes T, Kazatchkine MD, Latypov A. Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modelling. Int J Drug Policy. 2014;25(6):1163–73.CrossRefPubMed Vickerman P, Platt L, Jolley E, Rhodes T, Kazatchkine MD, Latypov A. Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modelling. Int J Drug Policy. 2014;25(6):1163–73.CrossRefPubMed
45.
go back to reference Toledo L, Codeco CT, Bertoni N, et al. Putting respondent-driven sampling on the map: insights from Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr. 2011;57(3):S136–43.CrossRefPubMed Toledo L, Codeco CT, Bertoni N, et al. Putting respondent-driven sampling on the map: insights from Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr. 2011;57(3):S136–43.CrossRefPubMed
46.
go back to reference McCreesh N, Johnston LG, Copas A, et al. Evaluation of the role of location and distance in recruitment in respondent-driven sampling. Int J Health Geogr. 2011;10(1):56.PubMedCentralCrossRefPubMed McCreesh N, Johnston LG, Copas A, et al. Evaluation of the role of location and distance in recruitment in respondent-driven sampling. Int J Health Geogr. 2011;10(1):56.PubMedCentralCrossRefPubMed
47.
go back to reference Young AM, Rudolph AE, Quillen D, Havens JR. Spatial, temporal and relational patterns in respondent-driven sampling: evidence from a social network study of rural drug users. J Epidemiol Community Health. 2014;68(8):792–8.PubMedCentralCrossRefPubMed Young AM, Rudolph AE, Quillen D, Havens JR. Spatial, temporal and relational patterns in respondent-driven sampling: evidence from a social network study of rural drug users. J Epidemiol Community Health. 2014;68(8):792–8.PubMedCentralCrossRefPubMed
48.
go back to reference Qiu P, Yang Y, Ma X, et al. Respondent-driven sampling to recruit in-country migrant workers in China: a methodological assessment. Scand J Public Health. 2012;40(1):92–101.CrossRefPubMed Qiu P, Yang Y, Ma X, et al. Respondent-driven sampling to recruit in-country migrant workers in China: a methodological assessment. Scand J Public Health. 2012;40(1):92–101.CrossRefPubMed
49.
go back to reference Springer SA, Larney S, Mehrjerdi ZA, Metzger D, Altice FL, Shoptaw S. Drug treatment as HIV prevention among women and girls who use drugs from a global perspective: progress, gaps and future directions. J Acquir Immune Defic Syndr. 2015 (In press). Springer SA, Larney S, Mehrjerdi ZA, Metzger D, Altice FL, Shoptaw S. Drug treatment as HIV prevention among women and girls who use drugs from a global perspective: progress, gaps and future directions. J Acquir Immune Defic Syndr. 2015 (In press).
51.
go back to reference Wickersham JA, Loeliger K, Marcus R, Pillai V, Kamarulzaman A, Altice FL. Correlates of lifetime and active injection drug use among women in Malaysia. Am J Drug Alcohol Abus. 2015 (In press). Wickersham JA, Loeliger K, Marcus R, Pillai V, Kamarulzaman A, Altice FL. Correlates of lifetime and active injection drug use among women in Malaysia. Am J Drug Alcohol Abus. 2015 (In press).
52.
go back to reference Department of Statistics Malaysia. 2010 Population and housing census of Malaysia: population distribution and basic demographic characteristics. 2011. Department of Statistics Malaysia. 2010 Population and housing census of Malaysia: population distribution and basic demographic characteristics. 2011.
53.
go back to reference Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention. Drug Alcohol Depend. 2011;116(1–3):151–7.PubMedCentralCrossRefPubMed Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention. Drug Alcohol Depend. 2011;116(1–3):151–7.PubMedCentralCrossRefPubMed
Metadata
Title
HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling
Authors
Alexander R. Bazazi
Forrest Crawford
Alexei Zelenev
Robert Heimer
Adeeba Kamarulzaman
Frederick L. Altice
Publication date
01-12-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 12/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-015-1191-y

Other articles of this Issue 12/2015

AIDS and Behavior 12/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.